ShadowBuys

SEC EDGAR · Company announcement

ABBV: Financial results

Filed 8-K for an event or period dated 2026-10-30. Financial results.

Follow ABBV
Became public
Oct 30, 2026, 7:51 AM EDT
Event / period date
Oct 30, 2026
Collected
Nov 7, 2026, 2:37 PM EST

Why this is connected

This filing identifies AbbVie Inc. as the issuer of the security. The company's SEC identifier connects it to ABBV.

Press Release dated ↗

Source evidence

Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition On October 30, 2026, AbbVie Inc. issued a press release announcing financial results for the third quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Exhibit 99.1 Press Release dated October 3 0 , 2026 (furnished pursuant to Item 2.02). 104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABBVIE INC. Date: October 30, 2026 By: /s/ Scott T. Reents Scott T. Reents Executive Vice President, Chief Financial Officer

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.